Stay updated on Pembrolizumab & Lanreotide for GI NETs Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page shows an administrative revision label: v3.3.4, replacing the previous v3.3.3. No core study content, eligibility criteria, locations, or outcomes were changed.
    Difference
    0.1%
    Check dated 2026-01-14T03:27:18.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a Locations section listing North Carolina (Duke University Medical Center, Durham) and South Carolina (Columbia and Lexington Medical Center) study sites, replacing the prior separate state location headings; removed the HHS Vulnerability Disclosure link in the footer as part of Revision: v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T21:56:50.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page footer revision label was updated from v3.2.0 to v3.3.2, indicating a minor update to the page metadata. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:28:23.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Removal of the government funding notice banner at the top of the ClinicalTrials.gov study page.
    Difference
    0.4%
    Check dated 2025-11-18T07:11:27.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    No substantive changes to the study details or eligibility criteria are evident between the two screenshots; any differences seem to be formatting, spacing, or UI elements rather than content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:13:27.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Major update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:50:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lanreotide for GI NETs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page.